Genscript Biotech Corporation (GNNSF)
EBITDA
$600.31M
TTM · Period ending: · USD

GNNSF EBITDA
What is ebitda?
EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.
Compare ebitda
GNNSF ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | EBITDA (USD) | Change |
|---|---|---|
| 329,662,582 | +363.85% | |
| 71,071,385 | — | |
| -249,423,000 | — | |
| -354,173,000 | — | |
| -465,512,174 | — | |
| -171,651,000 | — | |
| -92,586,155 | −359.45% | |
| 35,686,000 | −21.61% | |
| 45,521,000 | +20.08% | |
| 37,909,000 | +94.47% | |
| 19,493,000 | +48.26% | |
| 13,148,000 | +0.49% | |
| 13,084,000 | — |
Frequently asked questions: GNNSF ebitda
What is Genscript Biotech Corporation (GNNSF)'s current ebitda?
Genscript Biotech Corporation (GNNSF)'s latest reported ebitda (TTM) is $600.31M as of Jun 30, 2026. EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.
How much historical ebitda data is available for GNNSF?
Stock Alarm Pro provides 13 dated annual fiscal periods observations for Genscript Biotech Corporation (GNNSF)'s ebitda, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GNNSF's ebitda to peers or set an alert?
You can compare GNNSF's ebitda directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on GNNSF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance